MENU

Fox Chase’s Jeffrey Farma Admitted to Academy as Master Surgeon Educator

September 2, 2020

PHILADELPHIA (September 2, 2020)—Fox Chase Cancer Center’s Jeffrey Farma, MD, FACS, was recently admitted to the prestigious American College of Surgeons Academy of Master Surgeon Educators.

The academy operates under the American College of Surgeons (ACS) Division of Education. According to the academy, its purpose is to “recognize and assemble a cadre of renowned master surgeon educators who will work closely with the ACS Division of Education, to advance the science and practice of avant-garde surgical education and training.”

“This honor is a reflection of Dr. Farma’s expertise as a clinician, a researcher and an educator, as well as all of Fox Chase, and our surgical programs,” said Robert G. Uzzo, MD, MBA, FACS, chair of the Department of Surgical Oncology. “Part of our mission is education, and this recognition underscores our dedication to that end.”

“I am exceedingly honored and feel privileged to be included in this elite group of academic surgeons,” Farma said. “Ever since I started medical school I was very interested in education, and it paved my way throughout my career. One of the most rewarding parts of what I do is advocating for and educating the medical students, residents, and fellows I train, and to witness their future successes.”

Farma is the chief of the Division of General Surgery at Fox Chase as well as the co-director of the Melanoma and Skin Cancer Program. He is also a professor in the Department of Surgical Oncology and the program director of the Complex Surgical Oncology Fellowship.

Farma is a member of the translational research disease groups for colorectal and small intestine cancer, melanoma and skin cancer, and sarcoma and gastrointestinal stromal tumor cancer. Additionally, he has been recognized by Philadelphia magazine as a Top Doctor for the past five years.

Members of the academy are selected through a rigorous peer-review process. Academy members are expected to frequently participate in activities that contribute to its goals. That includes defining megatrends in surgical education and training; steering advances in the field; fostering innovation and collaboration; supporting faculty development and recognition; and underscoring the critical importance of surgical education and training in the changing milieu of health care.

Farma will be among a number of newly selected Members and Associate Members who will be inducted into the academy at a ceremony that will be held virtually on September 25.

      

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase